| For: | Jimenez-Tellez N, Greenway SC. Cellular models for human cardiomyopathy: What is the best option? World J Cardiol 2019; 11(10): 221-235 [PMID: 31754410 DOI: 10.4330/wjc.v11.i10.221] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v11/i10/221.htm |
| Number | Citing Articles |
| 1 |
Isaiah K. Mensah, Humaira Gowher. Signaling Pathways Governing Cardiomyocyte Differentiation. Genes 2024; 15(6) doi: 10.3390/genes15060798
|
| 2 |
Saeideh Edalati, Safoura Khajeniazi. Positive effect of Periostin on repair of Isopreternol induced ischemic damaged cardiomyocyte: an in vitro model. Regenerative Therapy 2022; 20 doi: 10.1016/j.reth.2022.03.003
|
| 3 |
M.I. Nasser, Xiao Qi, Shuoji Zhu, Yin He, Mingyi Zhao, Huiming Guo, Ping Zhu. Current situation and future of stem cells in cardiovascular medicine. Biomedicine & Pharmacotherapy 2020; 132 doi: 10.1016/j.biopha.2020.110813
|
| 4 |
Honglin Xu, Hongyuan Zhang, Tayyiba Azam, Susanne S. Hille, Yingjuan Liu, Min Zi, Jiaqing Lang, He Yu, Yujia Cao, Bernard D. Keavney, Tamer M. A. Mohamed, Jessica M. Miller, Riham R. E. Abouleisa, Ming Xu, Elizabeth J. Cartwright, Oliver J. Müller, Ming Lei, Xin Wang. A Novel Pak1 Activator Ameliorates ER Stress for HFpEF Therapy. Advanced Science 2026; doi: 10.1002/advs.76964
|
| 5 |
Kumud Tiwari. Advancements in Modeling-Based Therapeutics and Technology for Chronic Diseases. 2026; doi: 10.1016/B978-0-443-33877-9.00015-X
|
| 6 |
Mohamed M. Bekhite, P. Christian Schulze. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective. Cells 2021; 10(12) doi: 10.3390/cells10123483
|
| 7 |
Giulia Buonaiuto, Fabio Desideri, Adriano Setti, Alessandro Palma, Angelo D’Angelo, Giulio Storari, Tiziana Santini, Pietro Laneve, Daniela Trisciuoglio, Monica Ballarino. LncRNA HSCHARME is altered in human cardiomyopathies and promotes stem cell-derived cardiomyogenesis via splicing regulation. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-62754-2
|
| 8 |
Rafael Dariolli, Chiara Campana, Amy Gutierrez, Eric A. Sobie. In vitro and In silico Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic “COVID-19 Cardiomyocyte”. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.624185
|
| 9 |
Xin-Yi Wu, Yee-Ki Lee, Yee-Man Lau, Ka-Wing Au, Yiu-Lam Tse, Kwong-Man Ng, Chun-Ka Wong, Hung-Fat Tse. The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models. Pharmaceuticals 2024; 17(8) doi: 10.3390/ph17081030
|
| 10 |
Anabel Cámara‐Checa, Mar Álvarez, Josu Rapún, Sara Pérez‐Martín, Roberto Núñez‐Fernández, Marcos Rubio‐Alarcón, Teresa Crespo‐García, Lourdes R. Desviat, Eva Delpón, Ricardo Caballero, Eva Richard. Propionic Acidemia‐Induced Proarrhythmic Electrophysiological Alterations in Human iPSC‐Derived Cardiomyocytes. Journal of Inherited Metabolic Disease 2025; 48(3) doi: 10.1002/jimd.70030
|
| 11 |
Zulfugar T. Taghiyev, Borros Arneth, Afaf Altrawy, Rawan Mohamed, Aysha Ghazy, Dina Hamdy, Hussein Sabit. The Cardiovascular System. 2025; doi: 10.1016/B978-0-443-29890-5.00001-4
|
| 12 |
Adéla Krajčová, Vlasta Němcová, Milada Halačová, Petr Waldauf, Martin Balík, František Duška. Amiodarone but not propafenone impairs bioenergetics and autophagy of human myocardial cells. Toxicology and Applied Pharmacology 2023; 477 doi: 10.1016/j.taap.2023.116676
|
| 13 |
Nazanin Vaziri, Diogo Marques, Steven C. Greenway, Chad A. Bousman. The cellular mechanism of antipsychotic-induced myocarditis: A systematic review. Schizophrenia Research 2023; 261 doi: 10.1016/j.schres.2023.09.039
|
| 14 |
Ilaria Gisone, Antonella Cecchettini, Elisa Ceccherini, Elisa Persiani, Maria Aurora Morales, Federico Vozzi. Cardiac tissue engineering: Multiple approaches and potential applications. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.980393
|
| 15 |
Jinjuan Yang, Shaoxiang Chen, Fuyu Duan, Xiuxiu Wang, Xiaoxian Zhang, Boonxuan Lian, Meng Kou, Zhixin Chiang, Ziyue Li, Qizhou Lian. Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management. Cells 2022; 11(21) doi: 10.3390/cells11213511
|
| 16 |
Melania Lippi, Ilaria Stadiotti, Giulio Pompilio, Elena Sommariva. Human Cell Modeling for Cardiovascular Diseases. International Journal of Molecular Sciences 2020; 21(17) doi: 10.3390/ijms21176388
|
| 17 |
Esmeralda Alonso-Barroso, Belén Pérez, Lourdes Ruiz Desviat, Eva Richard. Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic Acidemia. International Journal of Molecular Sciences 2021; 22(3) doi: 10.3390/ijms22031161
|
| 18 |
A. L. Klass, M. I. Shadrina, P. A. Slominsky, E. V. Filatova. Prospects for the Use of Cell Cultures in Modeling Myocardial Diseases: Hypertrophic Cardiomyopathy. Cell and Tissue Biology 2024; 18(4) doi: 10.1134/S1990519X24700305
|
| 19 |
. 2024; doi: 10.70675/efe69219zfecfz40b5z983cz7599358e9783
|
| 20 |
Nerea Jimenez-Tellez, Damon Williams, Yu Liu, Mingqiang Wang, Mark Chandy, Joseph C. Wu. Transcriptomic analysis of nicotine on the cardiovascular system using a diverse population of human induced pluripotent stem cell-derived endothelial cells. Journal of Molecular and Cellular Cardiology 2025; 198 doi: 10.1016/j.yjmcc.2024.11.001
|
| 21 |
Nazanin Vaziri, Timothy E. Shutt, Wasi Karim, Thomas J. Raedler, Christos Pantelis, Naveen Thomas, Mahesh Jayaram, Steven C. Greenway, Chad A. Bousman. Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes. Molecular Psychiatry 2025; 30(8) doi: 10.1038/s41380-025-02935-z
|
| 22 |
Takahiro Iwamiya, Bertrand-David Segard, Yuimi Matsuoka, Tomomi Imamura, Vincenzo Lionetti. Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis. PLOS ONE 2020; 15(9) doi: 10.1371/journal.pone.0237810
|
| 23 |
Keyang Zhu, Xiaoming Bao, Yingchao Wang, Ting Lu, Ling Zhang. Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery. Biomedicine & Pharmacotherapy 2023; 157 doi: 10.1016/j.biopha.2022.113970
|
| 24 |
Magali Seguret, Eva Vermersch, Charlène Jouve, Jean-Sébastien Hulot. Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies. Biomedicines 2021; 9(5) doi: 10.3390/biomedicines9050563
|
| 25 |
Cátia D. Correia, Anita Ferreira, Mónica T. Fernandes, Bárbara M. Silva, Filipa Esteves, Helena S. Leitão, José Bragança, Sofia M. Calado. Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?. Cells 2023; 12(13) doi: 10.3390/cells12131727
|